EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Por Franceschi, Enrico, Stupp, Roger, van den Bent, Martin J., van Herpen, Carla, Laigle Donadey, Florence, Gorlia, Thierry, Hegi, Monika, Lhermitte, Benoit, Strauss, Lewis C., Allgeier, Anouk, Lacombe, Denis, Brandes, Alba A.
Publicado em 2012

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951

Por Kouwenhoven, Mathilde C.M., Gorlia, Thierry, Kros, Johan M., Ibdaih, Ahmed, Brandes, Alba A., Bromberg, Jacolien E.C., Mokhtari, Karima, van Duinen, Sjoerd G., Teepen, Johannes L., Wesseling, Pieter, Vandenbos, Fanny, Grisold, Wolfgang, Sipos, László, Mirimanoff, Rene, Vecht, Charles J., Allgeier, Anouk, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2009